Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.31 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12203096 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL16666935 | 0.82 | CYP1A2 (0.75) | CYP1A2USP2ALDH1A1LMNATSHR | |
| Gababutin SCHEMBL25615 | 0.80 | ALDH1A1 (0.95) | CYP1A2USP2ALDH1A1LMNATSHR | |
| SCHEMBL8287805 | 0.80 | CYP1A2 (0.87) | CYP1A2USP2ALDH1A1LMNATSHR | |
| SCHEMBL7252552 | 0.79 | USP2 (0.40) | CYP1A2USP2ALDH1A1LMNATSHR | |
| Gabapentin SCHEMBL4030100 | 0.78 | CYP1A2 (1.00) | CYP1A2USP2ALDH1A1LMNATSHR | |
| Hydrochloric Acid SCHEMBL5690559 | 0.78 | ALDH1A1 (0.83) | CYP1A2USP2ALDH1A1LMNATSHR | |
| SCHEMBL466183 | 0.78 | CYP1A2 (1.00) | CYP1A2USP2ALDH1A1LMNATSHR | |
| SCHEMBL6544499 | 0.78 | CYP1A2 (1.00) | CYP1A2USP2ALDH1A1LMNATSHR | |
| Gabapentin SCHEMBL179836 | 0.78 | CYP1A2 (1.00) | CYP1A2USP2ALDH1A1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888325-B1 | NOVEL CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS | WARNER LAMBERT CO (US) | 2002-05-29 | — | — | EP | claimed |
| US-5929088-A | TREATMENT OF EPILEPSY, FAINTING, NEURODEGENERATIVE DISORDERS, ANXIETY, PAIN, PANIC ATTACKS | WARNER-LAMBERT COMPANY (US) | 1999-07-27 | — | — | US | claimed |
| EP-0888325-A1 | NOVEL CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1999-01-07 | — | — | EP | claimed |
| WO-1997029101-A1 | NOVEL CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1997-08-14 | — | — | WO | claimed |
| WO-2007090661-A2 | ACTIVE SUBSTANCE COMBINATION COMPRISING AZOLYLCARBINOL COMPOUNDS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-08-16 | — | — | WO | disclosed |
| EP-0888325-B1 | NOVEL CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS | WARNER LAMBERT CO (US) | 2002-05-29 | — | — | EP | disclosed |
| US-5929088-A | TREATMENT OF EPILEPSY, FAINTING, NEURODEGENERATIVE DISORDERS, ANXIETY, PAIN, PANIC ATTACKS | WARNER-LAMBERT COMPANY (US) | 1999-07-27 | — | — | US | disclosed |
| EP-0888325-A1 | NOVEL CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997029101-A1 | NOVEL CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1997-08-14 | — | — | WO | disclosed |